title: Autologous PBSCT in patients with cardiac amyloidosis.
authors.forename: J M
authors.initials: JM
authors.lastname: Stevens
authors.forename: W N
authors.initials: WN
authors.lastname: Patton
authors.forename: D C
authors.initials: DC
authors.lastname: Heaton
authors.forename: R L
authors.initials: RL
authors.lastname: Spearing
authors.forename: G
authors.initials: G
authors.lastname: Shaw
authors.forename: D
authors.initials: D
authors.lastname: Bowie
authors.forename: D
authors.initials: D
authors.lastname: Smyth
authors.forename: R
authors.initials: R
authors.lastname: Comenzo
mesh_terms: D000686:Amyloidosis / Q000150:complications / Q000628:therapy*; D018952:Antigens, CD34 / Q000032:analysis; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000633:toxicity; D001804:Blood Transfusion, Autologous; D009202:Cardiomyopathies / Q000150:complications / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000633:toxicity; D008875:Middle Aged; D012770:Shock, Cardiogenic / Q000139:chemically induced; D013234:Stem Cells / Q000276:immunology
chemical_list: D018952:Antigens, CD34; D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan